Therapeutic opportunities to control tumor cell cycles
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s12094-006-0193-7.pdf
Reference58 articles.
1. Malumbres M, Barbacid M. RAS oncogenes: the first 50 years. Nat Rev Cancer. 2003;3:459–65.
2. Nurse, P. A long twentieth century of the cell cycle and beyond. Cell. 2000;100:71–8.
3. Massague, J.. G1 cell-cycle control and cancer. Nature 2004;432:298–306.
4. Malumbres M, Barbacid M. To cycle or no to cycle: a critical decision in cancer. Nat Rev Cancer. 2001;1:222–31.
5. Malumbres M, Carnero A. Cell cycle deregulation: a common motif in cancer. Progress Cell Cycle Res. 2003;5:5–18.
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An insight into the rational design of recent purine-based scaffolds in targeting various cancer pathways;Journal of Molecular Structure;2023-02
2. CDK inhibitor Palbociclib targets STING to alleviate autoinflammation;EMBO reports;2022-04-11
3. Design, synthesis, molecular docking and ADME studies of novel indole-thiazolidinedione derivatives and their antineoplastic activity as CDK6 inhibitors;New Journal of Chemistry;2021
4. Abemaciclib as an original inhibitor of cyclin-dependent kinase for the treatment of luminal HER2-negative disseminated breast cancer;Meditsinskiy sovet = Medical Council;2020-07-30
5. CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions;Current Oncology Reports;2019-02-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3